Since Pradaxa is available today in the US and Canada, There is an article Q&A type thing with one of the principle Investigators of the trials for Afib. One good thing is it is about 1/2 the proce they were expecting (but sitll high for a med you need 2 times a day forever IMO) http://www.theheart.org/article/1142899.do
New York, NY - Dabigatran (Pradaxa, Boehringer Ingelheim) will be available in both Canadian and US pharmacies as of today for its newly approved indication: to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, the manufacturer, Boehringer Ingelheim, has announced [1]. The company has also said the drug will be priced at a "wholesale-acquisition" cost of $6.75 per day, lower than expected based on the up to $12/day price in markets where it is already approved for limited duration use after hip and knee surgery.
Physicians who've waited decades for an alternative to warfarin now have a host of questions about how to use the drug and in whom. heartwire put some of these to Dr Michael Ezekowitz (Lankenau Institute for Medical Research, Wynnewood, PA), co-principal investigator on the pivotal RE-LY trial. more at link
New York, NY - Dabigatran (Pradaxa, Boehringer Ingelheim) will be available in both Canadian and US pharmacies as of today for its newly approved indication: to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, the manufacturer, Boehringer Ingelheim, has announced [1]. The company has also said the drug will be priced at a "wholesale-acquisition" cost of $6.75 per day, lower than expected based on the up to $12/day price in markets where it is already approved for limited duration use after hip and knee surgery.
Physicians who've waited decades for an alternative to warfarin now have a host of questions about how to use the drug and in whom. heartwire put some of these to Dr Michael Ezekowitz (Lankenau Institute for Medical Research, Wynnewood, PA), co-principal investigator on the pivotal RE-LY trial. more at link